Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
397
-
Total 13F shares, excl. options
-
55,400,378
-
Shares change
-
-833,150
-
Total reported value, excl. options
-
$9,303,697,145
-
Value change
-
-$146,566,478
-
Put/Call ratio
-
2.28%
-
Number of buys
-
205
-
Number of sells
-
-167
-
Price
-
$168.13
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2018
461 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2018.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 397 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,400,378 shares
.
Largest 10 shareholders include FMR LLC (5,748,743 shares), Vanguard Group Inc (4,882,984 shares), BlackRock Inc. (4,490,714 shares), PUTNAM INVESTMENTS LLC (4,318,748 shares), JPMORGAN CHASE & CO (1,912,173 shares), Bank of New York Mellon Corp (1,690,385 shares), TIAA CREF INVESTMENT MANAGEMENT LLC (1,332,172 shares), STATE STREET CORP (1,289,580 shares), Boston Partners (1,117,065 shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (1,112,735 shares).
This table shows the top 397 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.